These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25724312)

  • 61. A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions.
    Verma S; Gokhale R; Burgess DJ
    Int J Pharm; 2009 Oct; 380(1-2):216-22. PubMed ID: 19596059
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Nanosuspension: A Formulation Technology for Tackling the Poor Aqueous Solubility and Bioavailability of Poorly Soluble Drugs.
    Elsebay MT; Eissa NG; Balata GF; Kamal MA; Elnahas HM
    Curr Pharm Des; 2023; 29(29):2297-2312. PubMed ID: 37694786
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Preparation and characterization of freeze-dried 2-methoxyestradiol nanoparticle powders.
    Du B; Li XT; Zhao Y; A YM; Zhang ZZ
    Pharmazie; 2010 Jul; 65(7):471-6. PubMed ID: 20662313
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A brief literature and patent review of nanosuspensions to a final drug product.
    Chin WW; Parmentier J; Widzinski M; Tan EH; Gokhale R
    J Pharm Sci; 2014 Oct; 103(10):2980-99. PubMed ID: 25099918
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Recent Advances in Nanosuspension Technology for Drug Delivery.
    Arora D; Khurana B; Rath G; Nanda S; Goyal AK
    Curr Pharm Des; 2018; 24(21):2403-2415. PubMed ID: 29788880
    [TBL] [Abstract][Full Text] [Related]  

  • 66.
    Shariare MH; Altamimi MA; Marzan AL; Tabassum R; Jahan B; Reza HM; Rahman M; Ahsan GU; Kazi M
    Saudi Pharm J; 2019 Jan; 27(1):96-105. PubMed ID: 30662312
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Nanosuspensions in drug delivery: recent advances, patent scenarios, and commercialization aspects.
    Chavhan SS; Petkar KC; Sawant KK
    Crit Rev Ther Drug Carrier Syst; 2011; 28(5):447-88. PubMed ID: 22077201
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antiretroviral solid drug nanoparticles with enhanced oral bioavailability: production, characterization, and in vitro-in vivo correlation.
    McDonald TO; Giardiello M; Martin P; Siccardi M; Liptrott NJ; Smith D; Roberts P; Curley P; Schipani A; Khoo SH; Long J; Foster AJ; Rannard SP; Owen A
    Adv Healthc Mater; 2014 Mar; 3(3):400-11. PubMed ID: 23997027
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Amorphous isradipine nanosuspension by the sonoprecipitation method.
    Tran TT; Tran PH; Nguyen MN; Tran KT; Pham MN; Tran PC; Vo TV
    Int J Pharm; 2014 Oct; 474(1-2):146-50. PubMed ID: 25138256
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Nanosuspensions as advanced printing ink for accurate dosing of poorly soluble drugs in personalized medicines.
    Pardeike J; Strohmeier DM; Schrödl N; Voura C; Gruber M; Khinast JG; Zimmer A
    Int J Pharm; 2011 Nov; 420(1):93-100. PubMed ID: 21889582
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Formulation and evaluation of mucoadhesive buccal films impregnated with carvedilol nanosuspension: a potential approach for delivery of drugs having high first-pass metabolism.
    Rana P; Murthy RS
    Drug Deliv; 2013; 20(5):224-35. PubMed ID: 23651066
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Particle size reduction to the nanometer range: a promising approach to improve buccal absorption of poorly water-soluble drugs.
    Rao S; Song Y; Peddie F; Evans AM
    Int J Nanomedicine; 2011; 6():1245-51. PubMed ID: 21753876
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Controlled delivery of carvedilol nanosuspension from osmotic pump capsule: in vitro and in vivo evaluation.
    Liu D; Yu S; Zhu Z; Lyu C; Bai C; Ge H; Yang X; Pan W
    Int J Pharm; 2014 Nov; 475(1-2):496-503. PubMed ID: 25219321
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Nanosuspension-Based Drug Delivery Systems for Topical Applications.
    Aldeeb MME; Wilar G; Suhandi C; Elamin KM; Wathoni N
    Int J Nanomedicine; 2024; 19():825-844. PubMed ID: 38293608
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Fabrication of fenofibrate nanocrystals by probe sonication method for enhancement of dissolution rate and oral bioavailability.
    Ige PP; Baria RK; Gattani SG
    Colloids Surf B Biointerfaces; 2013 Aug; 108():366-73. PubMed ID: 23602990
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nanosuspension for parenteral delivery of a p-terphenyl derivative: preparation, characteristics and pharmacokinetic studies.
    Tian X; Li H; Zhang D; Liu G; Jia L; Zheng D; Shen J; Shen Y; Zhang Q
    Colloids Surf B Biointerfaces; 2013 Aug; 108():29-33. PubMed ID: 23528604
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Development and characterization of solid oral dosage form incorporating candesartan nanoparticles.
    Nekkanti V; Pillai R; Venkateshwarlu V; Harisudhan T
    Pharm Dev Technol; 2009; 14(3):290-8. PubMed ID: 19235553
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Process parameter dependent growth phenomena of naproxen nanosuspension manufactured by wet media milling.
    Bitterlich A; Laabs C; Krautstrunk I; Dengler M; Juhnke M; Grandeury A; Bunjes H; Kwade A
    Eur J Pharm Biopharm; 2015 May; 92():171-9. PubMed ID: 25766272
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Development of Silymarin nanocrystals lyophilized power applying nanosuspension technology].
    Zhao X; Wang G; Zhang B; Li H; Nie Q; Zang C; Zhao X
    Zhongguo Zhong Yao Za Zhi; 2009 Jun; 34(12):1503-8. PubMed ID: 19777833
    [TBL] [Abstract][Full Text] [Related]  

  • 80. In vivo absorption comparison of nanotechnology-based silybin tablets with its water-soluble derivative.
    Xu D; Ni R; Sun W; Li LC; Mao S
    Drug Dev Ind Pharm; 2015 Apr; 41(4):552-9. PubMed ID: 24495272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.